ArticleGenes2025

Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study.

Marcin Minta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.